Jiang Su Yida Chemical Co.,Ltd (SHE:300721)
China · Delayed Price · Currency is CNY 16.96
+0.10 (0.59%)
At close: Feb 27, 2026
SHE:300721 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 1,514 | 1,734 | 1,744 | 1,492 | 1,442 | 999.65 |
Other Revenue | 33.63 | 33.63 | 69.79 | 62.74 | 8.24 | 4.51 |
| 1,548 | 1,768 | 1,814 | 1,554 | 1,450 | 1,004 | |
Revenue Growth (YoY) | -13.10% | -2.55% | 16.72% | 7.16% | 44.44% | 5.21% |
Cost of Revenue | 1,526 | 1,580 | 1,614 | 1,268 | 1,152 | 912.45 |
Gross Profit | 21.97 | 188.12 | 200.34 | 286.39 | 298.25 | 91.71 |
Selling, General & Admin | 93.16 | 124.38 | 197.43 | 90.71 | 78.72 | 51.91 |
Research & Development | 19.07 | 21.82 | 25.04 | 24.5 | 24.93 | 21.11 |
Other Operating Expenses | 4.88 | 2.9 | 2.79 | 11.22 | 9.72 | 6.14 |
Operating Expenses | 118.99 | 148.7 | 227.54 | 125.9 | 114.6 | 79.98 |
Operating Income | -97.01 | 39.42 | -27.2 | 160.5 | 183.65 | 11.72 |
Interest Expense | -45.95 | -45.43 | -48.21 | -36.65 | -25.67 | -23.85 |
Interest & Investment Income | 1.05 | 1.1 | 2.46 | 2.52 | 1.35 | 1.36 |
Currency Exchange Gain (Loss) | 0.81 | 0.81 | 0.64 | -0.42 | -0.14 | -0.97 |
Other Non Operating Income (Expenses) | 0.49 | -0.32 | -0.27 | -0.24 | -0.2 | -0.84 |
EBT Excluding Unusual Items | -140.61 | -4.42 | -72.58 | 125.7 | 159 | -12.57 |
Gain (Loss) on Sale of Investments | 0.76 | - | - | - | - | - |
Gain (Loss) on Sale of Assets | -0.09 | -0.12 | 0.01 | -0.13 | -0.07 | -0.75 |
Asset Writedown | -10.78 | -0.22 | -1.98 | -2.44 | - | - |
Legal Settlements | -2 | -2 | - | - | - | - |
Other Unusual Items | 0.41 | 0.39 | 1.61 | -2.15 | 1.45 | 4.81 |
Pretax Income | -152.31 | -6.37 | -72.94 | 120.98 | 160.37 | -8.51 |
Income Tax Expense | -35.88 | -3.73 | -20.27 | 17.46 | 29.37 | -4.24 |
Earnings From Continuing Operations | -116.43 | -2.65 | -52.66 | 103.52 | 131 | -4.27 |
Minority Interest in Earnings | 21.71 | 12.18 | 17.37 | 6.06 | 0.84 | 0.39 |
Net Income | -94.72 | 9.53 | -35.29 | 109.58 | 131.84 | -3.88 |
Net Income to Common | -94.72 | 9.53 | -35.29 | 109.58 | 131.84 | -3.88 |
Net Income Growth | - | - | - | -16.88% | - | - |
Shares Outstanding (Basic) | 166 | 165 | 145 | 162 | 161 | 148 |
Shares Outstanding (Diluted) | 166 | 165 | 145 | 165 | 162 | 148 |
Shares Change (YoY) | 1.39% | 13.94% | -12.02% | 1.51% | 9.81% | -2.93% |
EPS (Basic) | -0.57 | 0.06 | -0.24 | 0.68 | 0.82 | -0.03 |
EPS (Diluted) | -0.57 | 0.06 | -0.24 | 0.67 | 0.81 | -0.03 |
EPS Growth | - | - | - | -18.12% | - | - |
Free Cash Flow | -107.94 | 142.6 | -125.13 | -83.19 | -20.04 | -267.67 |
Free Cash Flow Per Share | -0.65 | 0.86 | -0.86 | -0.51 | -0.12 | -1.81 |
Dividend Per Share | 0.030 | 0.030 | 0.100 | 0.079 | 0.053 | - |
Dividend Growth | -70.00% | -70.00% | 26.74% | 50.00% | - | - |
Gross Margin | 1.42% | 10.64% | 11.04% | 18.43% | 20.56% | 9.13% |
Operating Margin | -6.27% | 2.23% | -1.50% | 10.33% | 12.66% | 1.17% |
Profit Margin | -6.12% | 0.54% | -1.94% | 7.05% | 9.09% | -0.39% |
Free Cash Flow Margin | -6.98% | 8.07% | -6.90% | -5.35% | -1.38% | -26.66% |
EBITDA | -15.92 | 150.92 | 124.85 | 227.27 | 237.81 | 63.51 |
EBITDA Margin | -1.03% | 8.54% | 6.88% | 14.62% | 16.40% | 6.32% |
D&A For EBITDA | 81.09 | 111.5 | 152.05 | 66.78 | 54.16 | 51.78 |
EBIT | -97.01 | 39.42 | -27.2 | 160.5 | 183.65 | 11.72 |
EBIT Margin | -6.27% | 2.23% | -1.50% | 10.33% | 12.66% | 1.17% |
Effective Tax Rate | - | - | - | 14.43% | 18.31% | - |
Revenue as Reported | 1,548 | 1,768 | 1,814 | 1,554 | 1,450 | 1,004 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.